Open access
Oct 2026
Psychiatric Outcomes of Antiseizure Medications in Newly Diagnosed Focal Onset Epilepsy: From the Human Epilepsy Project Cohort Study.
People who were newly diagnosed with focal epilepsy on ASM monotherapy showed that levetiracetam was associated with approximately 2.8-fold risk of treatment withdrawal compared with lamotrigine because of psychiatric adverse events, and a better psychiatric tolerability profile for lamotrigine was demonstrated.
H. Altalib, Poojith Nuthalapati, Zhi-Yuan Zhang et al.
· Neurology Clinical Practice · 0 citations